期刊文献+

中西医结合治疗肝硬化腹水44例疗效观察 被引量:1

The effective observation on treating 44 cases of cirrhotic ascites in the integrative medicine
下载PDF
导出
摘要 目的:探讨中西医结合治疗肝硬化的临床疗效。方法:给予对照组常规西医治疗并对症治疗,治疗组在对照组的基础上加服中药自拟疏肝行水化瘀汤。结果:治疗组显效26例,有效15例,总有效率为93.18%,对照组显效9例,有效20例,总有效率为65.91%,两组疗效有显著性差异。结论:中西医结合可有效治疗肝硬化腹水,且疗效显著。 Objective: To observe the clinical effect of treating cirrhotic ascites in the integretive medicine. Methods: The control group was treated by common Western medicine, on the bases, the treatment group was added Shugan Xingshui Huayu decoction. Result: The treatment group markly cured for 26 cases, effective for 15 cases, the total effective rate for 93.18%, the control group markly cured for 9 cases, effective for 20 cases, the total effective rate for 65.91%, the effect of the two group had significant difference. Conclusion: It was effective that treating cirrhotic ascites in the integretive medicine, and was significant.
作者 何汶忠
出处 《中医临床研究》 2011年第6期89-89,91,共2页 Clinical Journal Of Chinese Medicine
关键词 肝硬化腹水 疏肝行水化瘀汤 中西医结合 疗效 Cirrhotic ascites Shugan Xingshui Huayu decoction In the integrative medicine Effect
  • 相关文献

参考文献2

二级参考文献3

共引文献8

同被引文献13

  • 1苏是苍,李承彬,胡勤明.肝纤维化和肝硬化不同阶段细胞因子水平变化[J].长江大学学报(自科版)(下旬),2006,3(1):219-220. 被引量:2
  • 2Subramaniam s, Stansberg C, Cunningham C. The interleukin 1 receptor family [J]. Dev Cornp Immunol, 2004, 28(5) :415-428.
  • 3Bortolami M, Kotsafti A, Cardin R, et el. Fas/FasL.system, IL-1 beta- expresion and apoptosis in chronic HBV and HEY liver disease [J]. J Viral Hepat, 2008, 15(7): 515-522.
  • 4Lemmem A, Gustot T, Dumez A, et al. An inhibitor of intedeukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease[J]. Clin Exp lmmunol, 2009.156 (3) : 518-527.
  • 5Jeshi-Barve S, Barve SS, Amaneherla K, et al. palmitie acid induces production of proinflammatory cytokine interleukin-8 from hepatecytes [J]. Hepatology, 2007, 46(3) : 823-830.
  • 6Ilmakunnas M, Hoekemtedt K, Maklsalo H, et al. Hepatic IL-8 release during groft procurement is associated with impaired graft function after human liver transplantation [J].Clin Transplant, 2009, 17(4) :96-97.
  • 7Zhao X.I, Don_g Q, Bindas J, et aI.TRIF and IRF-3 binding to the TNF promoter results in maerophage TNF dysregulation and steatosis induced by chronic ethanol [J]. Immunol, 2008, 181 (5) : 3049- 3056.
  • 8Bergstrom S, Ryhage R, Sarnuelsson B, et al. prostaglandins and related fators:The Structure of prostaglandin El, Fla, and Flb[J].J Biol Chem, 1963, 238(11) :3555-3564.
  • 9Merion RM. Prostaglandins in liver transplantation. Adv Exp Med Biol, 1997, 433 : 13-8.
  • 10Farkas S, Bolder U, Sehlittenbauer T, et al. Conditioning of liver grafts with prostaglandins improves bile acid transport [J]. Transplant Proc, 2005, 37(1): 435-438.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部